OneAscent Wealth Management LLC Has $275,000 Holdings in The Cigna Group (NYSE:CI)

OneAscent Wealth Management LLC cut its stake in The Cigna Group (NYSE:CI) by 3.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 996 shares of the health services provider’s stock after selling 38 shares during the period. OneAscent Wealth Management LLC’s holdings in The Cigna Group were worth $275,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of CI. Allstate Corp bought a new position in The Cigna Group in the 4th quarter worth approximately $2,293,000. Maridea Wealth Management LLC acquired a new stake in shares of The Cigna Group in the 4th quarter valued at $343,000. DnB Asset Management AS raised its position in shares of The Cigna Group by 6.7% during the fourth quarter. DnB Asset Management AS now owns 130,201 shares of the health services provider’s stock worth $35,954,000 after acquiring an additional 8,139 shares during the last quarter. Level Four Advisory Services LLC lifted its stake in shares of The Cigna Group by 12.1% during the fourth quarter. Level Four Advisory Services LLC now owns 1,941 shares of the health services provider’s stock valued at $536,000 after acquiring an additional 210 shares during the period. Finally, Orion Portfolio Solutions LLC boosted its holdings in The Cigna Group by 13.2% in the fourth quarter. Orion Portfolio Solutions LLC now owns 44,991 shares of the health services provider’s stock valued at $12,424,000 after acquiring an additional 5,258 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have weighed in on the company. Cantor Fitzgerald boosted their price objective on The Cigna Group from $350.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, March 20th. Stephens dropped their price target on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Oppenheimer reduced their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an “outperform” rating on the stock in a research note on Friday, January 31st. Royal Bank of Canada set a $355.00 target price on shares of The Cigna Group in a research report on Friday, January 31st. Finally, Sanford C. Bernstein lowered The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price target on the stock. in a research report on Thursday, February 6th. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $373.25.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, Director Elder Granger sold 2,376 shares of The Cigna Group stock in a transaction on Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the sale, the director now directly owns 5,471 shares in the company, valued at approximately $1,697,924.85. The trade was a 30.28 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Nicole S. Jones sold 4,904 shares of the business’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the sale, the insider now directly owns 29,421 shares in the company, valued at $9,065,198.52. This trade represents a 14.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 43,751 shares of company stock worth $13,603,991. Corporate insiders own 0.70% of the company’s stock.

The Cigna Group Stock Up 0.1 %

The Cigna Group stock opened at $324.97 on Friday. The company has a 50 day moving average of $304.67 and a 200-day moving average of $314.08. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The stock has a market capitalization of $88.94 billion, a PE ratio of 26.55, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the prior year, the firm earned $6.79 earnings per share. On average, equities research analysts anticipate that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 20th. Investors of record on Wednesday, March 5th were given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 1.86%. The ex-dividend date of this dividend was Wednesday, March 5th. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio (DPR) is currently 49.35%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.